Pharma News

Gene transplantation in injured heart develops biological pacemakers

  • Posted on: 21 July 2014
  • By: PharmaTutor News

(21st July, 2014); Cardiologists at the Cedars-Sinai Heart Institute have developed a minimally invasive gene transplant procedure that changes unspecialized heart cells into “biological pacemaker” cells that keep the heart steadily beating.

Google & Novartis join hands for development of SMART LENS

  • Posted on: 21 July 2014
  • By: PharmaTutor News

(21st July, 2014); Novartis & Google join together to develop smart contact lens which will be useful in monitoring blood sugar level for diabetic patients and restore focusing capacity of eyes in patients with presbyopia. Alcon, eye care division of Novartis, has entered into an agreement with a division of Google Inc. to in-license its “smart lens” technology for all ocular medical uses.

Relief India Trust NGO: Fighting Thalassemia through Human Touch

  • Posted on: 18 July 2014
  • By: PharmaTutor News

(Business Wire India; 18th July, 2014); For three-year-old Sneha, life is a struggle in continuity. A patient of Thalassemia major, Sneha battles death every single day. Her parents, despite being advised to undergo medical tests to diagnose her condition when she was in her mother’s womb, chose to disregard this warning. Now, this unawareness and lack of understanding might cost them dear. Unfortunately, they lost their four-year-old son two years ago due to the same blood disorder.

Possibly new generation of anti-diabetic drug - stops diabetes in its tracks and reverses insulin insensitivity with no side effects

  • Posted on: 17 July 2014
  • By: PharmaTutor News

(17th July, 2014); Researchers from Salk discovered new and more effective diabetic drug which could lead for safe & new generation of anti-diabetic drugs. They injected single injection of the protein FGF1 which is enough to restore blood sugar levels to a healthy range for more than two days.

India topped in antibiotics use across the world

  • Posted on: 15 July 2014
  • By: PharmaTutor News

(15th July, 2014); Study published by researchers shown that use of antibiotics is increasing day by day across the world. Unsurprisingly India is the largest consumer of antibiotics in 2010. As per study, use is not being effectively monitored by health officials, from doctors to hospital workers to clinicians, noted the researchers. Consequently, antibiotic use is both rampant and less targeted. That reality is driving antibiotic resistance at an unprecedented rate.

Drinking alocohol provides no heart benefits - dissent prior studies

  • Posted on: 11 July 2014
  • By: PharmaTutor News

(11th July, 2014); Recent research asking questions to prior studies which stated that one drink per day may promote cardiovascular health. As per recent research published in The BMJ led by the Perelman School of Medicine at the University of Pennsylvania, reducing the amount of alcoholic beverages consumed, even for light-to-moderate drinkers, may improve cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index (BMI) and blood pressure.

HIV reappeared in child seemingly cured

  • Posted on: 11 July 2014
  • By: PharmaTutor News

(11th July, 2014); The child known as the “Mississippi baby”—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable levels of HIV after more than two years of not taking antiretroviral therapy without evidence of virus, according to the pediatric HIV specialist and researchers involved in the case.

Unichem Laboratories to appeal the decision of European Commission

  • Posted on: 10 July 2014
  • By: PharmaTutor News

(10th July, 2014); On 9th July 2014, the European Commission (the EU’s top competition regulator) decided to impose a wholly unjustified fine on Niche /Unichem (jointly and severally) contending that it had acted in breach of EU Antitrust Rules. The European Commission reached this conclusion because its subsidiary, Niche Generics Ltd (Niche), agreed to settle financially crippling patent litigation with Laboratories Servier (Servier) at the beginning of 2005.

Pages